Navigation LinksBiology NewsHealth NewsBiology TechnologyMedicine Technology


We're sorry, that page (http://www.bio-medicine.org/biology-technology-1/oncogenex-reports-third-quarter-2009-financial-results-14740-5/;/a> ) was not found.

Search biology technology 1 oncogenex reports third quarter 2009 financial results 14740 5 ; a>  at Google

Search biology technology 1 oncogenex reports third quarter 2009 financial results 14740 5 ; a>  at Yahoo

Search biology technology 1 oncogenex reports third quarter 2009 financial results 14740 5 ; a>  at Msn

Google
 
Breaking Biology News(10 mins):Studying hair of ancient Peruvians answers questions about stress 2BIO-key(R) Selected as 2009 Industry Innovator in Biometrics by SC Magazine 2BIO-key(R) Selected as 2009 Industry Innovator in Biometrics by SC Magazine 3ADA releases updated position paper on nutrient supplementation 2Northeast Health Care Quality Foundation QIO Uses Milliman Care Guidelines 28R 29 for Medicare Medicaid Reviews 51607 1Northeast Health Care Quality Foundation QIO Uses Milliman Care Guidelines 28R 29 for Medicare Medicaid Reviews 51607 2Northeast Health Care Quality Foundation QIO Uses Milliman Care Guidelines 28R 29 for Medicare Medicaid Reviews 51607 3New Policy Statement from Society for Adolescent Medicine Urges Inclusion of Adolescent and Young Adult Health Issues in All Health Care Reform Legisl 51602 1New Policy Statement from Society for Adolescent Medicine Urges Inclusion of Adolescent and Young Adult Health Issues in All Health Care Reform Legisl 51602 2New Policy Statement from Society for Adolescent Medicine Urges Inclusion of Adolescent and Young Adult Health Issues in All Health Care Reform Legisl 51602 3Watson Pharmaceuticals Receives a Complete Response Letter for Its 24 Week Formulation of TRELSTAR 28R 29 28triptorelin pamoate 29 NDA from US FDA 51600 1Watson Pharmaceuticals Receives a Complete Response Letter for Its 24 Week Formulation of TRELSTAR 28R 29 28triptorelin pamoate 29 NDA from US FDA 51600 2Watson Pharmaceuticals Receives a Complete Response Letter for Its 24 Week Formulation of TRELSTAR 28R 29 28triptorelin pamoate 29 NDA from US FDA 51600 3
Breaking Medicine News(10 mins):Health News:Syclo Mobile Field Service Product, Resulting from Co-innovation with SAP, Selected by Medical System Supplier 2Health News:Syclo Mobile Field Service Product, Resulting from Co-innovation with SAP, Selected by Medical System Supplier 3Health News:Syclo Mobile Field Service Product, Resulting from Co-innovation with SAP, Selected by Medical System Supplier 4Health News:Cohen Independent Research Group Issues a 'Buy' Rating With a Target Price of $2.48 for VHGI; 8K filed regarding $50,000,000.00 Treasure Gulch Gold Reserves 2Health News:Cohen Independent Research Group Issues a 'Buy' Rating With a Target Price of $2.48 for VHGI; 8K filed regarding $50,000,000.00 Treasure Gulch Gold Reserves 3Health News:Cohen Independent Research Group Issues a 'Buy' Rating With a Target Price of $2.48 for VHGI; 8K filed regarding $50,000,000.00 Treasure Gulch Gold Reserves 4Health News:Cohen Independent Research Group Issues a 'Buy' Rating With a Target Price of $2.48 for VHGI; 8K filed regarding $50,000,000.00 Treasure Gulch Gold Reserves 5Health News:Webcast Alert: MicroRNA: The Year in Review 2Health News:PrimeDoc Renews and Expands Three-Year Contract with Ingenious Med 2Health News:PrimeDoc Renews and Expands Three-Year Contract with Ingenious Med 3Health News:NCCN Guidelines for Non-Small Cell Lung Cancer Updated to Incorporate Maintenance Therapy 2Health News:NCCN Guidelines for Non-Small Cell Lung Cancer Updated to Incorporate Maintenance Therapy 3
Breaking Medicine Technology:PRA International Hosts an Infectious Diseases Audio Conference 2PRA International Hosts an Infectious Diseases Audio Conference 3Sanofi Pasteur Global Dengue Vaccine Clinical Program Expanded in Latin America 2Sanofi Pasteur Global Dengue Vaccine Clinical Program Expanded in Latin America 3Sanofi Pasteur Global Dengue Vaccine Clinical Program Expanded in Latin America 4Sanofi Pasteur Global Dengue Vaccine Clinical Program Expanded in Latin America 5Perrigo Confirms Filing for Generic Version of Clobex(R) Spray and Announcement of Lawsuit by Galderma and Dermalogix 2Perrigo Confirms Filing for Generic Version of Clobex(R) Spray and Announcement of Lawsuit by Galderma and Dermalogix 3Inspiration Biopharmaceuticals Presents Safety Data on IB1001 a Novel Recombinant Factor IX for the Treatment of Hemophilia at the International Soci 13015 1Inspiration Biopharmaceuticals Presents Safety Data on IB1001 a Novel Recombinant Factor IX for the Treatment of Hemophilia at the International Soci 13015 2Allscripts e prescribing Tool to Be Offered on New AMA Web Solution 51593 1Allscripts e prescribing Tool to Be Offered on New AMA Web Solution 51593 2Allscripts e prescribing Tool to Be Offered on New AMA Web Solution 51593 3Allscripts e prescribing Tool to Be Offered on New AMA Web Solution 51593 4Allscripts e prescribing Tool to Be Offered on New AMA Web Solution 51593 5The Power of Functional Foods is the Key to Fi Asia Chinas Success 51591 1The Power of Functional Foods is the Key to Fi Asia Chinas Success 51591 2The Power of Functional Foods is the Key to Fi Asia Chinas Success 51591 3